Illumina Supports Rockefeller Foundation with Global Pathogen Sequencing Collaboration

By: 3BL Media

SOURCE: Illumina

DESCRIPTION:

The Rockefeller Foundation said on Wednesday that it has committed over $20 million in research funding and formed a number of collaborations to boost pathogen sequencing capabilities and data sharing worldwide to combat future pandemics.

To improve pathogen sequencing data technologies, the foundation is working with Concentric by Ginkgo and data.org in collaboration with the Wellcome Trust, the Development Data Partnership, and FIND. It is also collaborating on various projects with Global.health, a research network that includes the University of Oxford, Harvard University, Northeastern University, Boston Children's Hospital, Georgetown University, the University of Washington, Johns Hopkins Center for Health Security, and Google; the Global Fund; Illumina; Oxford Nanopore Technologies; Scripps Research; Thermo Fisher Scientific; Qiagen; and Verily.

Read the full article here

Tweet me: The Rockefeller Foundation has committed over $20 million in research funding and formed a number of collaborations to boost pathogen sequencing capabilities and data sharing worldwide to combat future pandemics. https://bit.ly/3vApo20 @Illumina

KEYWORDS: illumina, Rockefeller Foundation, Pathogen Sequencing

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.